<DOC>
	<DOC>NCT00796224</DOC>
	<brief_summary>The purpose of this study was to determine the pharmacokinetics (PK), safety and clinical response following a single dose of either 30 mg/kg IR (Immediate Release) or 60 mg/kg ER (Extended Release) formulation in pediatric subjects 6 months to 6 years of age inclusive.</brief_summary>
	<brief_title>Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Subjects age 6 months to &lt; 12 years. Have clinical signs/symptoms of acute otitis media in at least one ear. Parent(s)/legal guardian(s) provide written informed consent. Clinical significant other disease. Recent use of investigational drugs, prescription or nonprescription drugs.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>azithromycin, pharmacokinetics, pediatrics</keyword>
</DOC>